Uploaded November 2020 | Updated September 2026, 14 hours ago
Jacob Stegenga (University of Cambridge)
Conference: Responsible Life Science Policy between Public and Private Funding
Description: The COVID-19 crisis has again emphasized the importance of science for a well-functioning global society. In particular, we now turn to life sciences for answers that could influence the whole human race, from our very survival to details about the development and management of resources. Thus, responsible life science policy is of global relevance. This raises new questions, such as how best to distribute a future vaccine, or what agents can be counted as blameworthy in cases of failure. This international, online workshop brings together experts to discuss one of the many new questions prompted by the current crisis, specifically, how are we to fund pandemic science? Is this best left to each country, or are multinational standards to be preferred? What role should be played by private companies, as opposed to national funding agencies? What kinds of healthcare inequalities follow from inequalities in funding?
Organizers: Carl Fredrich von Weizsäcker Center (University of Tübingen), Centre for Philosophy of Science (University of Geneva), and Forum for Advancing Science and Education through Philosophy (Advise).
Jacob Stegenga (University of Cambridge)
Conference: Responsible Life Science Policy between Public and Private Funding
Description: The COVID-19 crisis has again emphasized the importance of science for a well-functioning global society. In particular, we now turn to life sciences for answers that could influence the whole human race, from our very survival to details about the development and management of resources. Thus, responsible life science policy is of global relevance. This raises new questions, such as how best to distribute a future vaccine, or what agents can be counted as blameworthy in cases of failure. This international, online workshop brings together experts to discuss one of the many new questions prompted by the current crisis, specifically, how are we to fund pandemic science? Is this best left to each country, or are multinational standards to be preferred? What role should be played by private companies, as opposed to national funding agencies? What kinds of healthcare inequalities follow from inequalities in funding?
Organizers: Carl Fredrich von Weizsäcker Center (University of Tübingen), Centre for Philosophy of Science (University of Geneva), and Forum for Advancing Science and Education through Philosophy (Advise).
